产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 20654 | Lorundrostat | 1820940-17-7 | 98% Min. |  |
| Lorundrostat is an aldosterone synthase inhibitor. | ||||
| 20625 | LEO-32731 | 1353546-86-7 | 98% Min. |  |
| LEO-32731 is a bioactive chemical. | ||||
| 20588 | Losmapimod | 585543-15-3 | 98% Min. |  |
| Losmapimod, also know as GW856553 or GW856553X or GSK-AHAB, is a drug developed by Gl | ||||
| 20577 | LY3522348 | 2568608-48-8 | 98% Min. |  |
| 20551 | Lin281632 | 108825-65-6 | 98% Min. |  |
| Lin28 1632, is a RNA binding protein Lin28 inhibitor. Lin281632 promotes mESC differe | ||||
| 20531 | LUNA18 | unknown | 98% Min. |  |
| LUNA18 is a N-alkyl-rich cyclic peptide | ||||
| 20477 | LQZ-7I | 195822-23-2 | 98% Min. |  |
| LQZ-7I is a malarial protease PfSUB1 inhibitor. LQZ-7I showed significantly improved | ||||
| 20461 | LSN2463359 | 1401031-52-4 | 98% Min. |  |
| LSN2463359 is a novel positive allosteric modulators of the mGlu₅ receptor. | ||||
| 20438 | LFM-A13 | 244240-24-2 | 98% Min. |  |
| LFM-A13 is a potent and selective inhibitor of Bruton's tyrosine kinase (BTK). LF | ||||
| 20266 | Linzagolix | 935283-04-8 | ≧98.0% |  |
| Linzagolix 是一种新型的口服 GnRH 受体拮抗剂，可有效治疗子宫内膜 | ||||
| 21244 | LY-3475070 | 2375815-63-5 | 98% Min. |  |
| LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alo | ||||
| 210507 | LP-261 | 915412-67-8 | ≧98.0% |  |
| LP-261 is a novel tubulin targeting anticancer agent that binds at the colchicine sit | ||||
| 21225 | LM11A-31 HCl | 1243259-19-9 | 98% Min. |  |
| 20113001 | LVN84663 | 103784-66-3 | 98% Min. |  |
| LVN84663 is a useful reagent for determination of blood coagulating protease. It was | ||||
| 2091908 | LUN42518 | 47142-51-8 | 98% Min. |  |
| LUN42518, also known as Phentolamine Analogue 1, is an analogue of phentolamine. Phen | ||||
| 2073106 | Lerociclib HCl (G1T38 HCl) | 2097938-59-3 | ≧98.0% |  |
| Lerociclib HCl (G1T38 dihydrochloride)是一种分化型口服CDK4 / 6抑制剂，对 | ||||
| 2071555 | Lobaplatin | 135558-11-1 | 98% Min. |  |
| Lobaplatin (D-19466) is a diastereometric mixture of platinum(II) complexes containin | ||||
| 2071524 | Lixivaptan | 168079-32-1 | 98% Min. |  |
| Lixivaptan, laso known as CRTX-080; VPA-985; WAY-VPA-985, is a potent, orally active, | ||||
| 2071505 | LAU159 | 2055050-87-6 | 98% Min. |  |
| LAU159 is a potent modulator of α6β3γ2 GABAA receptor. | ||||
| 2071502 | Lificiguat | 170632-47-0 | 98% Min. |  |
| Lificiguat, also known as YC-1, is a inhibitor of Hypoxia-inducible factor-1alpha (HI | ||||
| 20732 | Lanraplenib | 1800046-95-0 | 98% |  |
| GS-9876（lanraplenib）是一种高度选择性的口服SYK抑制剂，主要用于狼 | ||||
| 2061309 | Linperlisib free base | 1702816-75-8 | 98% Min. |  |
| Linperlisib, also known as YY-20394 and PI3Kδ-IN-2, is a potent and selective PI3Kδ | ||||
| 2061307 | L006235 | 294623-49-7 | 98% Min. |  |
| L006235 is a potent, reversible cathepsin K inhibitor (IC50 = 0.25 nM) that displays | ||||
| 2051510 | LML-134 | 1542135-76-1 | 98% |  |
| LML134 是一种具有口服活性，高选择性 H3R (组胺 3 受体) 反向激动剂 | ||||
| 2042701 | LUT-014 | 2274819-46-2 | 98% Min. | |
| LUT-014 is a B-Raf Inhibitor. Leveraging the paradoxical effect of B-Raf Inhibitors, | ||||
| 2041502 | LSZ102 | 2135600-76-7 | 98% Min. |  |
| LSZ102 is a potent ERα antagonist and degrader. LSZ102 showed ERα degradation IC50 | ||||
| 204502 | LUN42589 | 1848242-58-9 | 98% Min. |  |
| LUN42589，也称为PI3K / mTOR抑制剂2，是一种有效的双重pan-PI3K / mTOR抑 | ||||
| 204302 | Lerociclib | 1628256-23-4 (free base) | 98% | .png) |
| Lerociclib，也称为G1T38，是一种口服，有效和选择性的CDK4 / 6抑制剂 | ||||
| 6111904 | Lemborexant (E-2006) | 1369764-02-2 | 98% Min. | _1369764-02-2.png) |
| Lemborexant（ E-2006, CAS 1369764-02-2）是食欲素OX 1和OX 2受体的双重拮抗 | ||||
| 193262 | LY2794193 | 2173037-97-1 | >98% |  |
| LY2794193是一种高效选择性的mGlu3受体激动剂。 | ||||